Literature DB >> 9217922

Advances in understanding the pharmacological properties of antisense oligonucleotides.

S T Crooke1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217922     DOI: 10.1016/s1054-3589(08)60136-2

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


× No keyword cloud information.
  14 in total

1.  Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides.

Authors:  P Lorenz; T Misteli; B F Baker; C F Bennett; D L Spector
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

Review 2.  Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

Authors:  R L Juliano; S Alahari; H Yoo; R Kole; M Cho
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

3.  Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies.

Authors:  P Lorenz; B F Baker; C F Bennett; D L Spector
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

4.  Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration.

Authors:  H Wang; Q Cai; X Zeng; D Yu; S Agrawal; R Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 5.  Fomivirsen: clinical pharmacology and potential drug interactions.

Authors:  Richard S Geary; Scott P Henry; Lisa R Grillone
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance.

Authors:  Manya Warrier; Diana M Shih; Amy C Burrows; Daniel Ferguson; Anthony D Gromovsky; Amanda L Brown; Stephanie Marshall; Allison McDaniel; Rebecca C Schugar; Zeneng Wang; Jessica Sacks; Xin Rong; Thomas de Aguiar Vallim; Jeff Chou; Pavlina T Ivanova; David S Myers; H Alex Brown; Richard G Lee; Rosanne M Crooke; Mark J Graham; Xiuli Liu; Paolo Parini; Peter Tontonoz; Aldon J Lusis; Stanley L Hazen; Ryan E Temel; J Mark Brown
Journal:  Cell Rep       Date:  2015-01-15       Impact factor: 9.423

7.  The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome.

Authors:  Gwynneth Thomas; Jenna L Betters; Caleb C Lord; Amanda L Brown; Stephanie Marshall; Daniel Ferguson; Janet Sawyer; Matthew A Davis; John T Melchior; Lawrence C Blume; Allyn C Howlett; Pavlina T Ivanova; Stephen B Milne; David S Myers; Irina Mrak; Vera Leber; Christoph Heier; Ulrike Taschler; Jacqueline L Blankman; Benjamin F Cravatt; Richard G Lee; Rosanne M Crooke; Mark J Graham; Robert Zimmermann; H Alex Brown; J Mark Brown
Journal:  Cell Rep       Date:  2013-10-03       Impact factor: 9.423

8.  Targeting IκB kinase β in Adipocyte Lineage Cells for Treatment of Obesity and Metabolic Dysfunctions.

Authors:  Robert N Helsley; Yipeng Sui; Se-Hyung Park; Zun Liu; Richard G Lee; Beibei Zhu; Philip A Kern; Changcheng Zhou
Journal:  Stem Cells       Date:  2016-03-28       Impact factor: 6.277

9.  Antisense Tcf inhibits the neoplastic growth of liver cancer cells.

Authors:  Ying Jiang; Xin-Da Zhou; Yin-Kun Liu; Xiao-Wu Huang; Yan Zhao; Qiang Xue; Rui-Xa Sun; Jie Chen; Xin Wu
Journal:  J Cancer Res Clin Oncol       Date:  2004-11       Impact factor: 4.553

10.  Real time detection of DNA.RNA hybridization in living cells.

Authors:  D L Sokol; X Zhang; P Lu; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.